| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |